Def6 regulates endogenous type-I interferon responses in osteoblasts and suppresses osteogenesis

Zhonghao Deng1, Courtney Ng1, Kazuki Inoue1,2

  • 1Arthritis and Tissue Degeneration Program and David Z. Rosensweig Genomics Research Center, Hospital for Special Surgery, New York, United States.

Elife
|December 29, 2020
PubMed

Insights

Deficiency in DEF6 (a gene) impairs bone remodeling by suppressing osteoblast function and enhancing bone resorption, leading to osteoporosis. This highlights DEF6's role in immune regulation of bone.

Area of Science:

  • Immunology
  • Bone Biology
  • Genetics

Background:

  • Bone remodeling is a tightly regulated process involving bone resorption and formation.
  • The precise mechanisms governing bone remodeling remain incompletely understood.
  • DEF6 has been identified as a novel genetic locus associated with bone mineral density.

Purpose of the Study:

  • To investigate the role of Def6 in bone remodeling.
  • To elucidate the molecular mechanisms by which Def6 influences bone formation and resorption.
  • To explore the potential link between Def6, immune signaling, and bone health.

Main Methods:

  • Utilized Def6-deficient (Def6-/-) mice models.
  • Performed RNA sequencing (RNAseq) analysis on osteoblasts.
  • Investigated osteoblastogenesis and osteoclastogenesis.
  • Examined type-I interferon (IFN) signaling pathways.

Main Results:

  • Def6 acts as a novel regulator of osteoblasts, suppressing osteoblastogenesis and bone formation.
  • Def6 deficiency leads to increased bone resorption and osteogenesis, with resorption dominating and causing osteoporosis.
  • Def6 inhibits osteoclast and osteoblast differentiation via endogenous type-I IFN-mediated feedback.
  • Def6 is a key upstream regulator of IFNβ and IFN-stimulated genes (ISGs) in osteoblasts.

Conclusions:

  • Def6 plays a critical role in regulating bone remodeling.
  • Def6 exhibits a novel immunoregulatory function in bone metabolism.
  • These findings provide insights into the interplay between the immune system and bone remodeling, potentially offering new therapeutic targets for osteoporosis.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
9.5K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.5K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.4K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
8.8K